AI Article Synopsis
- - Henoch-Schonlein purpura (HSP) is the leading type of systemic vasculitis seen in children.
- - There is no agreed-upon treatment for skin-only symptoms of HSP, and traditional corticosteroid therapy was ineffective in one case.
- - An 11-year-old patient with severe skin lesions was successfully treated with intravenous immunoglobulins, leading to quick and lasting symptom improvement.
Article Abstract
Henoch-Schonlein purpura (HSP) is the most common systemic vasculitis in childhood. There is no consensus about the management for isolated cutaneous manifestations in HSP. We describe a case of HSP presenting with severe skin lesions that did not respond to standard therapy with corticosteroids. The 11-year-old child was treated with intravenous immunoglobulins, which induced rapid and persistent resolution of symptomatology.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/pde.13715 | DOI Listing |
Publication Analysis
Top Keywords
henoch-schonlein purpura
8
intravenous immunoglobulins
8
successful treatment
4
treatment hemorrhagic
4
hemorrhagic bullous
4
bullous henoch-schonlein
4
purpura intravenous
4
immunoglobulins henoch-schonlein
4
purpura hsp
4
hsp common
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!